← Back to Search

Mindfulness-Based Intervention for Opioid Use Disorder

Waitlist Available
Led By Cynthia Price, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
willing to forego (non-study) manual (e.g., massage) and/or mind-body therapies (e.g., mindfulness meditation) for 3 months
diagnosed with opioid use disorder
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This trial will test if a mindfulness-based intervention can help people with opioid use disorder who are receiving medication treatment to reduce opioid use and improve mental and physical health.

Who is the study for?
This trial is for individuals enrolled in a medication treatment program for opioid use disorder who are stable on their current regimen, fluent in English, and willing to commit to the study's requirements. Pregnant women over 24 weeks gestation or with unknown gestation, those showing psychosis or cognitive impairment, or unable to remain in treatment for the trial duration are excluded.Check my eligibility
What is being tested?
The study tests Mindful Awareness in Body-oriented Therapy (MABT) as an add-on to standard Medication for Opioid Use Disorder (MOUD). Participants will be randomly assigned to receive either MABT+MOUD or MOUD alone and will be evaluated over time to see which group fares better regarding opioid use, mental and physical health, cravings, and treatment retention.See study design
What are the potential side effects?
Since MABT is a mindfulness-based intervention focusing on body awareness without medication changes, significant side effects aren't anticipated. However, participants may experience emotional discomfort when engaging with mindfulness practices that encourage increased awareness of bodily sensations.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
You agree to stop receiving non-study manual therapies (like massages) and mind-body therapies (like meditation) for 3 months.
You have been diagnosed with addiction to opioid drugs.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time Line Follow-back

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MABT* + Medication TreatmentExperimental Treatment1 Intervention
Mindful Awareness in Body-oriented Therapy + Medication Treatment
Group II: Treatment as UsualActive Control1 Intervention
Treatment as Usual is medication for the treatment of opioid use disorder
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindful Awareness in Body-oriented Therapy
Completed Phase 1

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,733 Previous Clinical Trials
1,841,969 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
829 Previous Clinical Trials
668,625 Total Patients Enrolled
Cynthia Price, PhD4.840 ReviewsPrincipal Investigator - University of Washington
Medical School - University of Arizona
University of California, Los Angeles, Residency in Pediatrics
2 Previous Clinical Trials
45 Total Patients Enrolled
2Patient Review
I felt like she was rushing me through the appointment. I was in and out in less than 10 minutes and it cost me $45.

Media Library

Mindful Awareness in Body-oriented Therapy Clinical Trial Eligibility Overview. Trial Name: NCT04082637 — N/A
Opioid Use Disorder Research Study Groups: MABT* + Medication Treatment, Treatment as Usual
Opioid Use Disorder Clinical Trial 2023: Mindful Awareness in Body-oriented Therapy Highlights & Side Effects. Trial Name: NCT04082637 — N/A
Mindful Awareness in Body-oriented Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT04082637 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research actively seeking participants?

"As per clinicaltrials.gov, this medical trial is still in the process of recruiting participants. The first advertisement was posted on August 14th 2019 and updated as recently as August 29th 2022."

Answered by AI

What is the cap on participants for this clinical trial?

"Affirmative. Clinicaltrials.gov records reflect that this trial, which was first shared on August 14th 2019, is currently accepting applicants. A total of 330 participants need to be recruited from 4 different medical hubs."

Answered by AI
~54 spots leftby Apr 2025